Delivery Order SPE2DB22D2206-SPE2DB24FHV60
Award Date
6/20/24
Potential Completion Date
7/12/24
Potential Value
$7.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IBRANCE 100 MG TABLET 7S, a pharmaceutical product, with a ceiling value of $8,122.48 and a period of performance through July 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of IBRANCE 75 MG TABLET 7S, a pharmaceutical product, with a ceiling value of $48,743.76. The contract is a firm-fixed-price delivery order with a period of performance through July 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of IBRANCE 100 MG TABLET 7S. The contract has a firm fixed price and a ceiling value of $7,796.30, with a period of performance through May 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This is a federal contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,484.74, is for the delivery of IBRANCE 125 MG TABLET 7S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of May 17, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of pharmaceuticals, specifically the drug IBRANCE 100 MG TABLET 7S, with a ceiling value of $7,796.30 and an ultimate completion date of April 23, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to...
This is a federal delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,796.30 firm-fixed-price contract is for the supply of IBRANCE 100 MG TABLET 7S, a prescription drug product, with a period of performance through November 1, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with various federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of pharmaceutical products, specifically IBRANCE 100 MG TABLET 7S, with a total ceiling value of $31,176.78. The contract is a Delivery Order with a Firm Fixed Price pricing type, with a period of performance ending on September 5, 2024. The contract is not designated as a set-aside. AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,123.96 delivery order contract is for the supply of the prescription medication IBRANCE 75 MG TABLET 7S. The contract is a firm fixed-price, non-set-aside award with a performance period through June 2, 2025. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IBRANCE 125 MG TABLET 7S, a pharmaceutical product, with a ceiling value of $8,118.08 and a performance period ending on July 14, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,067.35, is for the delivery of IBRANCE 75 MG CAPSULE 21S, a pharmaceutical product. The contract has a period of performance through March 21, 2025 and is a firm fixed-price contract. The contract is not set aside for any specific socioeconomic program. AmerisourceBergen holds a...